LUPIN vs SANOFICONR: Stock Comparison

LUPIN vs SANOFI CONS HEALTHC IND LUpdated 11 Sept 26, 4:08 PM ISTNSE & company filings

LUPIN is the larger company by market capitalisation. LUPIN shows a lower P/E, while SANOFI CONS HEALTHC IND L shows a higher ROE, a higher dividend yield and faster revenue growth. These are relative readings on individual metrics — weigh valuation against growth, margins, leverage and capital efficiency rather than treating any single number as decisive.

Metric snapshot

LUPIN leads 5; SANOFICONR leads 8 of 13

Not a rating

Interactive comparison

Compare the numbers that shape the decision

Every row uses its own scale. Switch lenses to compare like with like.

LUPINSANOFICONR

Valuation lens

What price are you paying?

Market CapContext only
₹95,836 Cr
₹9,314 Cr
P/E RatioLUPIN has the lower reading
17.33x
35.01x
P/B RatioLUPIN has the lower reading
4.27x
26.77x
EPSLUPIN has the higher reading
₹59.37
₹29.87
Book ValueContext only
₹492.38
₹166.73
Dividend YieldSANOFICONR has the higher reading
0.86%
1.85%

✓ marks the usual favourable reading; it is not a recommendation.

Key Differences

Market Cap
LUPIN is the larger company
₹95,836 Cr vs ₹9,314 Cr
P/E Ratio
LUPIN has a lower P/E
17.33x vs 35.01x
P/B Ratio
LUPIN has a lower P/B
4.27x vs 26.77x
EPS
LUPIN has higher earnings per share
₹59.37 vs ₹29.87
Dividend Yield
SANOFICONR has a higher dividend yield
1.85% vs 0.86%
Revenue Growth (TTM YoY)
SANOFICONR has faster revenue growth
32.8% vs 31.9%
EPS Growth (TTM YoY)
LUPIN has faster EPS growth
89% vs 35.7%
Qtr Sales Growth
SANOFICONR has stronger quarterly sales growth
2.84% vs -13.35%

Each difference is a single, relative reading — StockeZee does not name an overall winner.

Profile

MetricLUPINSANOFICONR
SectorHealthcareHealthcare
IndustryPharmaceuticalsPharmaceuticals

Price

MetricLUPINSANOFICONR
Live Price₹2,095₹4,023.4
Day Change0.83%-1.62%
Volume6.22 L4,396
52-Week High₹2,529.5₹5,357
52-Week Low₹1,900₹3,975
Distance from 52W High-17.18%-24.89%

Valuation

MetricLUPINSANOFICONR
Market Cap₹95,836 Cr₹9,314 Cr
P/E Ratio17.33x35.01x
P/B Ratio4.27x26.77x
EPS₹59.37₹29.87
Book Value₹492.38₹166.73
Dividend Yield0.86%1.85%

Growth

MetricLUPINSANOFICONR
Revenue Growth (TTM YoY)31.9%32.8%
EPS Growth (TTM YoY)89%35.7%
Qtr Sales Growth-13.35%2.84%
Qtr Profit Growth91.58%1.47%

Profitability & Leverage

MetricLUPINSANOFICONR
ROE23.79%67.16%
ROCE23.47%2,813.76%
Net Margin17.65%27.58%
Operating Margin26.14%37.04%
Debt to Equity0.26x0x

Shareholding

As of Jun 2026 • change vs previous quarter
MetricLUPINSANOFICONR
Promoter Holding46.57%
FII Holding22.42% 0.71 pp2.6% 0.16 pp
DII Holding24.65% 0.67 pp17.86% 0.29 pp
Public Holding6.08% 0.03 pp8.27% 0.13 pp

How to Read This Comparison

Valuation ratios (P/E, P/B) use the latest consolidated figures where available; growth numbers compare against the same period last year; shareholding percentages come from the most recent quarterly filings, with the change shown against the prior quarter. A "more favourable" highlight is relative between these two companies only — it is not a rating, a recommendation, or a comparison against the wider sector. Rows with no reported data for either company are hidden rather than shown empty.

Deep-dive each company on its stock page for quarterly results, technicals, filings and the full peer set: LUPIN and SANOFI CONS HEALTHC IND L.

Data source: NSE and company filings via StockeZee. This comparison is informational — it is not investment advice, and StockeZee is not a SEBI-registered investment adviser.